Experiment 639011

Compounds isolated

Details

PropertyValue
Pharmacology
OrganismEmpty organism
CitationZI,XL: AGARWAL,R:. (1999). MODULATION OF MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION AND CELL CYCLE REGULATORS BY THE POTENT SKIN CANCER PREVENTIVE AGENT SILYMARIN.. 263(2)
Amount utilized
Compound isolated
DiseaseSILYMARIN TREATMENT OF CELLS RESULTED IN A SIGNIFICANT INHIBITION OF MITOGEN ACTIVATED PROTEIN KINASE (MAPK)/ERK1/2 ACTIVATION ONLY AT LOWER DOSES, WHEREAS HIGHER DOSES ACTIVATED MAPK/JNK1. THESE DIFFERENTIAL RESPONSES OF SILYMARIN WERE ACCOMPAINED BY ITS GROWTH INHIBITORY AND APOPTOTIC CELL DEATH EFFECTS AT LOW AND HIGH DOSES, RESPECTIVELY. SILYMARIN-CAUSED GROWTH INHIBITION WAS VIA BOTH G2-M AND G1 ARRESTS DUE TO A SIGNIFICANT DECREASE IN THE KINASE ACTIVITY AND PROTEIN LEVEL OF CDKS AND CYCLINS. DOSES OF SILYMARIN WERE FROM 10-150 MG/ML.
Dose amountVAR
Number1
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionDOSE